Combination bendamustine and rituximab offers an effective treatment option for older, sicker patients with chronic lymphocytic leukemia.
The sharp decline in quality of life in IPF patients is similar to that seen in lung cancer patients, in contrast to the more gradual trend seen...
ATLANTA - Dr. Yadav Sapkota of St. Jude Children's Research Hospital discusses the identification of a genetic variant that is strongly associated...
ATLANTA – Although HER2 expression in osteosarcoma and rhabomyosarcoma is too low for HER2-targeted therapies such...
A longtime antifungal standard, amphotericin, may hold the key to reducing or even preventing the chronic infections that affect patients with...
WASHINGTON - Off-label therapies discussed by Dr. Friedman include dapsone, hydroxychloroquine, and pentoxifylline.
On the heels of increased reports of breast implant–related anaplastic large cell lymphoma, researchers report a case of lymphoma that may be...
Necrotizing Infection of the Upper Extremity: A Veterans Affairs Medical Center Experience (2008-2017)
Necrotizing infection of the upper extremity is a rare pathology with a substantial risk of amputation and mortality that...
WASHINGTON – PRN1008 blocks BTK receptors on B cells, thus forestalling the B-cell mediated inflammatory cascade.
Are immunocompromised patients ever out of the woods after the original health issue is resolved? A new study suggests not.